GT Biopharma, Inc. (GTBP) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2017 | $0 | — |
| 2016 | $0 | — |
| 2015 | $0 | -100.0% |
| 2014 | $57.0K | -74.8% |
| 2013 | $226.0K | +140.4% |
| 2012 | $94.0K | +95.8% |
| 2011 | $48.0K | -26.2% |
| 2010 | $65.0K | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2017 | $0 | — |
| 2016 | $0 | — |
| 2015 | $0 | -100.0% |
| 2014 | $57.0K | -74.8% |
| 2013 | $226.0K | +140.4% |
| 2012 | $94.0K | +95.8% |
| 2011 | $48.0K | -26.2% |
| 2010 | $65.0K | — |